Cargando…
Australian clinicians and chemoprevention for women at high familial risk for breast cancer
OBJECTIVES: Effective chemoprevention strategies exist for women at high risk for breast cancer, yet uptake is low. Physician recommendation is an important determinant of uptake, but little is known about clinicians' attitudes to chemoprevention. METHODS: Focus groups were conducted with clini...
Autores principales: | Keogh, Louise A, Hopper, John L, Rosenthal, Doreen, Phillips, Kelly-Anne |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687421/ https://www.ncbi.nlm.nih.gov/pubmed/19409108 http://dx.doi.org/10.1186/1897-4287-7-9 |
Ejemplares similares
-
How do women at increased, but unexplained, familial risk of breast cancer perceive and manage their risk? A qualitative interview study
por: Keogh, Louise A, et al.
Publicado: (2011) -
Motivators of Inappropriate Ovarian Cancer Screening: A Survey of Women and Their Clinicians
por: Macdonald, Courtney, et al.
Publicado: (2020) -
Validation study of risk prediction models for female relatives of Australian women with breast cancer
por: MacInnis, R, et al.
Publicado: (2012) -
RE: Chemopreventive Agents to Reduce Mammographic Breast Density in Premenopausal Women: A Systematic Review of Clinical Trials
por: Hopper, John L, et al.
Publicado: (2021) -
Uptake of exemestane chemoprevention in postmenopausal women at increased risk for breast cancer
por: Aktas, Bilge, et al.
Publicado: (2016)